CHM.AX down 50% to A$0.001 intraday ASX 24 Mar 2026: what drives the selloff

CHM.AX stock fell sharply intraday on 24 Mar 2026, dropping 50.00% to A$0.001 on the ASX. The move followed thin liquidity and no immediate clinical updates, leaving investors to price in higher execution risk for the biotech. We examine trading details, fundamentals, technicals and a short-term Meyka AI forecast to explain why the stock sits at a new low on the ASX.